Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 9Non-metastatic Castration-resistant Prostate Cancer 4Neoplasm Metastasis 2Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 2Urogenital Neoplasms 1Sleep Initiation and Maintenance Disorders 1Non-metastatic Prostate Cancer 1Metastatic Hormone-sensitive Prostate Cancer 1Fatigue 1Depression 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Advanced Prostate Carcinoma 1

Interventions

enzalutamide 1darolutamide 1apalutamide 1abiraterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Advanced Prostate Carcinoma × darolutamide × Clear all
NCT05612880 2025-01-09

Physical Function During ARSI Treatment

UNC Lineberger Comprehensive Cancer Center

Completed
24 enrolled
Genitourinary

Advanced Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡